Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLGX
2501
DELISTED
Corelogic, Inc.
CLGX
| $2.69M | ﹤0.01% |
54,544
-44,795
| -45% | -$2.28M |
|
2502
Brink's
BCO
$4.69B
| $2.69M | ﹤0.01% |
38,597
+27,328
| +243% | +$2.11M |
|
2503
PUT
Gogo Inc
GOGO
$392M
| $2.69M | ﹤0.01% |
517,800
+63,400
| +14% | +$281K |
|
2504
PUT
Akamai
AKAM
$16.8B
| $2.69M | ﹤0.01% |
36,700
+9,800
| +36% | +$736K |
|
|
FTR
2505
PUT
DELISTED
Frontier Communications Corp.
FTR
| $2.69M | ﹤0.01% |
413,644
-174,700
| -30% | -$955K |
|
2506
CALL
Molson Coors Class B
TAP
$7.83B
| $2.68M | ﹤0.01% |
43,600
-13,200
| -23% | -$873K |
|
2507
Graham Holdings Company
GHC
$4.97B
| $2.68M | ﹤0.01% |
4,628
+3,190
| +222% | +$1.81M |
|
2508
B&G Foods
BGS
$277M
| $2.68M | ﹤0.01% |
97,492
+57,049
| +141% | +$1.77M |
|
2509
PUT
State Street SPDR S&P Bank ETF
KBE
$1.73B
| $2.67M | ﹤0.01% |
57,400
-62,700
| -52% | -$3.05M |
|
2510
PUT
Abercrombie & Fitch
ANF
$5.24B
| $2.67M | ﹤0.01% |
126,500
+83,200
| +192% | +$2.02M |
|
|
RPT
2511
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $2.67M | ﹤0.01% |
196,100
+59,523
| +44% | +$795K |
|
|
MNTA
2512
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $2.67M | ﹤0.01% |
101,372
+60,933
| +151% | +$1.65M |
|
2513
Vanguard Industrials ETF
VIS
$8.49B
| $2.67M | ﹤0.01% |
18,052
-2
| -0% | -$288 |
|
2514
Horace Mann Educators
HMN
$2.12B
| $2.66M | ﹤0.01% |
59,290
+29,338
| +98% | +$1.33M |
|
2515
Cavco Industries
CVCO
$4.57B
| $2.66M | ﹤0.01% |
10,511
+4,770
| +83% | +$1.1M |
|
2516
Grupo Cibest SA
CIB
$23.1B
| $2.66M | ﹤0.01% |
63,691
+2,291
| +4% | +$103K |
|
|
GES
2517
DELISTED
Guess Inc
GES
| $2.65M | ﹤0.01% |
117,293
+57,431
| +96% | +$1.3M |
|
|
ANDV
2518
PUT
DELISTED
Andeavor
ANDV
| $2.65M | ﹤0.01% |
17,276
-5,300
| -23% | -$783K |
|
|
SPPI
2519
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $2.65M | ﹤0.01% |
157,815
+44,267
| +39% | +$958K |
|
|
STL
2520
DELISTED
Sterling Bancorp
STL
| $2.65M | ﹤0.01% |
120,474
-153,434
| -56% | -$3.49M |
|
|
AVTA
2521
DELISTED
Avantax, Inc. Common Stock
AVTA
| $2.65M | ﹤0.01% |
65,749
+27,393
| +71% | +$998K |
|
|
PRSP
2522
DELISTED
Perspecta Inc. Common Stock
PRSP
| $2.65M | ﹤0.01% |
102,834
-312,429
| -75% | -$7.29M |
|
|
WBC
2523
DELISTED
WABCO HOLDINGS INC.
WBC
| $2.64M | ﹤0.01% |
22,388
+3,852
| +21% | +$465K |
|
|
SGEN
2524
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.64M | ﹤0.01% |
34,200
+27,800
| +434% | +$2.05M |
|
2525
Hubbell
HUBB
$27.5B
| $2.63M | ﹤0.01% |
19,706
+4,816
| +32% | +$591K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.